Medication Assisted Treatment. This plan covers medication assisted treatment for substance use disorders, including methadone maintenance treatment. Please see the Summary of Medical Benefits for specific copayments for these services.
Medication Assisted Treatment the prescription of medication related to SUD treatment services, or the assessment of the side effects or results of that medication conducted by staff lawfully authorized to provide such services and/or order laboratory testing within their scope of practice or licensure. This means long-acting injectable Vivitrol which is reimbursed for onsite administration and physicians and licensed prescribers in DMC-ODS programs will be reimbursed for the ordering, prescribing, administering, and monitoring.
Medication Assisted Treatment. This shall include dosing of buprenorphine, naloxone, and disulfiram when medically appropriate.
Medication Assisted Treatment. MAT services may be provided onsite with approval for 4 Incidental Medical Services from DHCS. Medically necessary MAT services must be provided in 5 accordance with an individualized treatment plan determined by a licensed physician or LPHA working 6 within their scope of practice.
7 a. MAT services must be provided in compliance with Policy and Procedures submitted to 8 DHCS for IMS designation. CONTRACTOR must ensure ability to continue MAT after discharge 9 through linkage to appropriate prescriber. MAT shall include the assessment, treatment planning, 10 ordering, prescribing, administering, and monitoring of all medications for SUDs.
11 b. CONTRACTOR shall provide administration of buprenorphine, naltrexone (oral and 12 injectable), acamprosate, disulfiram, and vivitrol. Other approved medications in the treatment of SUDs 13 may also be prescribed and administered, as medically necessary.
14 c. CONTRACTOR must provide care coordination with treatment and ancillary service 15 providers and facilitate transitions between levels of care. Beneficiaries may simultaneously participate 16 in MAT services and other ASAM LOCs.
17 d. CONTRACTOR must participate in the ADMINISTRATOR’S Medication Monitoring 18 practices process as a quality assurance measure. Medication Monitoring is to assure the appropriateness 19 of medication prescriptions for Mental Health and Recovery (MHRS) clients and to establish practices for 20 monitoring the safety and effectiveness of medication practices in MHRS.
Medication Assisted Treatment. “MAT”) DISTRIBUTION AND OTHER OPIOID-RELATED TREATMENT
1. Increase distribution of MAT to individuals who are uninsured or whose insurance does not cover the needed service;
2. Provide education to school-based and youth-focused programs that discourage or prevent misuse;
3. Provide MAT education and awareness training to healthcare providers, EMTs, law enforcement, and other first responders; and
4. Provide treatment and recovery support services such as residential and inpatient treatment, intensive outpatient treatment, outpatient therapy or counseling, and recovery housing that allow or integrate medication and with other support services.
Medication Assisted Treatment. Providers will have procedures for linkage/integration for beneficiaries requiring medication assisted treatment. Provider staff will regularly communicate with physicians of beneficiaries who are prescribed these medications unless the beneficiary refuses to consent to sign a 42 CFR part 2 compliant release of information for this purpose.
Medication Assisted Treatment. (MAT) are approved medications in combination with behavioral therapies to provide a whole client approach to treating substance use disorders. Clients seeking Outpatient, Residential or Recovery Residences/Sober Living and have concurrent MAT shall not be delayed access to substance use disorder treatment and recovery services due to the client’s medical status as it relates to MAT. Providers shall develop a policy, which includes how the program informs clients and educates staff about the MAT available at the program if applicable. The policy shall also include the assessment of a client’s MAT needs, administration and storage of medications, and training of staff. Provider staff shall be trained in the area of MAT protocols to include all portions of these Standards pertaining to monitoring of persons undergoing detoxification. If, while in treatment, a client exhibits signs and symptoms of withdrawal or behaviors that are a cause for concern for the provider and is believed to be attributable to the client’s medication, the SUS treatment provider staff should address this clinically with the client and the client prescriber. Treatment plans shall be flexible and adjusted as required with review and consult the prescribing physician.
Medication Assisted Treatment. 18 a. CONTRACTOR must offer or have an effective referral process in place to the most 19 clinically appropriate MAT services pursuant to the requirements set forth in DHCS information notices.
Medication Assisted Treatment. MAT") DISTRIBUTION AND OTHER OPIOID-RELATED TREATMENT
1. Increase distribution of MAT to individuals who are uninsured or whose insurance does not cover the needed service;
2. Provide education to school-based and youth-focused programs that discourage or prevent misuse;
3. Provide MAT education and awareness training to healthcare providers, EMTs, law enforcement, and other first responders; and
4. Provide treatment and recovery support services such as residential and inpatient treatment, intensive outpatient treatment, outpatient therapy or counseling, and recovery housing that allow or integrate medication and with other support services. 14 As used in this Schedule A, words like "expand," "fund," "provide" or the like shall not indicate a preference for new or existing programs.
Medication Assisted Treatment. Psychiatric evaluation, medication management services and care coordination to assist patients in abstaining from alcohol.
